The human epidermoid carcinoma cell line, A431, was treated with 100 ng/mL recombinant human HGF for five minutes to induce tyrosine phosphorylation of HGF R. Serial dilutions of lysates were analyzed by (A) IP-Western ...read more
A431 cells were untreated or treated with 100 ng/mL recombinant human HGF for five minutes. ELISA and IP-Western blot (inset) analyses were done using 50 μg and 500 μg of lysate, respectively. IP-Western blots for ...read more
A431 cells were treated with 100 ng/mL recombinant human HGF for five minutes. The indicated amounts of recombinant extracellular domains of human HGF R (Catalog #358-MT), human EGF R (Catalog #1095-ER) or human IGF-I ...read more
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human Phospho-HGFR/c-MET DuoSet IC ELISA, 2 Plate
AUTS9
cMET
c-MET
EC 2.7.10
EC 2.7.10.1
hepatocyte growth factor receptor
HGF R
HGF receptor
HGF/SF receptor
HGFR
Met (c-Met)
met proto-oncogene (hepatocyte growth factor receptor)
met proto-oncogene tyrosine kinase
MET
oncogene MET
Proto-oncogene c-Met
RCCP2
Scatter factor receptor
SF receptor
Tyrosine-protein kinase Met
Background
HGF receptor, a product of the proto-oncogene c-met, is a heterodimeric transmembrane glycoprotein that is a receptor-type tyrosine kinase. c-MET is synthesized as a single-chain precursor (pr170) which undergoes post-translational glycosylation and proteolytic cleavage to give rise to the heterodimeric mature form.